Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ (227,373) $ (612,545)
Adjustments to reconcile net income (loss) to net cash provided by (used by) operating activities:    
Depreciation and amortization 8,656 8,054
Bad debt expense 27,942 6,125
Amortization of discount on investment in account receivable (36,353) (46,192)
Gain on sale of investment in Brighter Day Health (53,058) 0
Increase in accrued of investment interest income (940) (2,351)
Gain on investment in securities, at fair value (65,140) 0
Decrease (increase) in operating assets    
Cash in attorney trust accounts 314,536 0
Finance leases receivable 31,382 0
Accounts receivable - trade 7,152 12,541
Prepaid expenses and other current assets 12,299 19,236
Employee advances (11,265) (4,100)
Increase (decrease) in operating liabilities    
Accounts payable (12,389) 12,289
Accrued expenses (6,922) (11,035)
Deferred revenue 60,904 0
Accrued salary, retirement and benefits - related party 15,794 94,249
Net cash provided by (used by) operating activities 65,225 (523,729)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from receivable - Bhang Corporation 1,987,099 0
Purchase of investment securities (101,441) (1,049,086)
Cash advanced on convertible notes receivable 0 (100,000)
Proceeds from convertible notes receivable 4,140 0
Cash advanced on notes receivable (100,000) (700,000)
Proceeds from notes receivable 14,965 5,200
Deposits on equipment to be leased (557,855) 0
Addition to finance receivables (507,706) 0
Purchases of property and equipment (2,399) (3,134)
Proceeds from sale of investment in BDH 109,000 0
Proceeds from investment in receivable 117,000 0
Net cash provided by (used by) investing activities 962,803 (1,847,020)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Warrants converted to common stock, net of costs 387,909 2,203,105
Issuance of Series Q preferred shares, net of cost 109,985 0
Payments on long-term debt (15,782) (19,996)
Non-controlling interest distribution (2,745) (982)
Net cash provided by (used by) financing activities 479,367 2,182,127
Net change in cash 1,507,395 (188,622)
Beginning cash 834,190 1,311,338
Ending cash 2,341,585 1,122,716
SUPPLEMENTARY INFORMATION:    
Cash paid for interest 8,128 4,113
Cash paid for income taxes 10,894 8,800
NON-CASH INVESTING AND FINANCING TRANSACTIONS:    
Shareholder assumption of warrant liability resulting in increased liability to shareholder 0 (80,054)
Contractual interest in legal recovery purchased through issuance of 288,890 shares of restricted common stock in a private offering 0 600,002
Conversion of Electrum convertible notes receivable to equity interest In Electrum 86,256 107,772
Bhang Corporation Receivable cancelled by return of Mentor Common Stock $ 228,150 $ 0